StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.75−0.06 (-1.57%)

Close on Nov 18, 2026Market cap $226.76MP/E –Yield –

Vanda Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Vanda Pharmaceuticals's EV/EBITDA was 10.5× on Oct 31, 2023, against 10.3× a year earlier. Over the last 5 years it ranged from 1.5× to 113.2×, with a median of 15.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 202310.5×−33.7
2022Dec 30, 202244.2×+33.6
2021Dec 31, 202110.6×−7.0
2020Dec 31, 202017.6×−5.4
2019Dec 31, 201923.0×−85.1
2018Dec 31, 2018108.1×+103.2
2016Jan 29, 20164.9×−0.7
2015Dec 31, 20155.7×+4.4
2011Jul 29, 20111.2×–

More Vanda Pharmaceuticals figures

See a number that looks wrong?